Assessment of tuberculosis among male prisoners in Shiraz central prison, south of Iran.
Social Determinants of Health,
Vol. 7 (2021),
8 June 2021
,
Page 1-8
https://doi.org/10.22037/sdh.v7i1.35024
Abstract
Background: Prisons play an important role in the prevalence of Tuberculosis (TB) in a region. This study aimed to determine the situation of TB in high-risk male prisoners in Shiraz central prison of Fars province in southern Iran.
Methods: This cross-sectional study (June-October 2018) was conducted on male prisoners in Shiraz central prison, southern Iran. According to 4 criteria, the prisoners were determined as high-risk prisoners for TB, and para clinical tests included three sputum samples and chest radiograph were performed for them. Then, the high risk and low risk participants were compared in terms of demographic characteristics and past medical history.
Results: Among 2,995 prisoners, only 108 (3.6%) had at least one of the high-risk criteria. But after performing further TB tests for these prisoners, no prisoners with TB disease were found. The high-risk prisoners were statistically older than low-risk prisoners (38.30±9.74 vs. 35.17±9.62, P=0.001). Also, the length of incarceration was statistically different in both groups (P=0.002), and drug abuse was more in high-risk group (P<0.001). Moreover, high risk prisoners used cigarettes/day more (14.87±11.55 vs. 9.71±9.09, P<0.001), but both groups were not different in term of the marital status (P=0.519), educational level (P=0.662), job (P=0.39), and nationality (P=0.342).
Conclusion: Our results showed that none of the high-risk prisoners for TB had positive test. The length of incarceration, drug abuse, smoking, as well as age were more in high-risk prisoners in comparing low risk group.
- Tuberculosis
- Prisoners
- Iran
How to Cite
References
Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367(9514):938-40. doi: 10.1016/S0140-6736(06)68384-0.
World Health Organization. Global tuberculosis report 2019. Available from: https://www.who.int/tb/publications/global_report/en/
Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis Incidence in Prisons: A Systematic Review. PLoS Med. 2010; 7(12): e1000381. doi: 10.1371/journal.pmed.1000381.
Banu S, Hossain A, Uddin MK, Uddin MR, Ahmed T, Khatun R, et al. Pulmonary Tuberculosis and Drug Resistance in Dhaka Central Jail, the Largest Prison in Bangladesh. PLoS ONE. 2010;5(5). PLoS One. 2010; 5(5): e10759. doi: 10.1371/journal.pone.0010759.
Alavi SM, Bakhtiarinia P, Eghtesad M, Albaji A, Salmanzadeh S. A comparative study on the prevalence and risk factors of tuberculosis among the prisoners in khuzestan, South-west iran. Jundishapur J Microbiol. 2014;7(12):e18872. doi: 10.5812/jjm.18872.
Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol. 2003;32(5):794-9. doi: 10.1093/ije/dyg247.
Winetsky DE, Almukhamedov O, Pulatov D, Vezhnina N, Dooronbekova A, Zhussupov B. Prevalence, risk factors and social context of active pulmonary tuberculosis among prison prisoners in Tajikistan. PLoS One. 2014;9(1):e86046. doi: 10.1371/journal.pone.0086046.
Gizachew Beza M, Hunegnaw E, Tiruneh M. Prevalence and Associated Factors of Tuberculosis in Prisons Settings of East Gojjam Zone, Northwest Ethiopia. Int J Bacteriol. 2017;2017:3826980. doi: 10.1155/2017/3826980.
Ali S, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, et al. Prevalence of Pulmonary Tuberculosis among Prison prisoners in Ethiopia, a Cross-Sectional Study. PLoS One. 2015;10(12):e0144040. doi: 10.1371/journal.pone.0144040.
Abebe DS, Bjune G, Ameni G, Biffa D, Abebe F. Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons. Int J Tuberc Lung Dis. 2011;15(5):668-73. doi: 10.5588/ijtld.10.0363.
Farhoudi B, SeyedAlinaghi S, Hosseini M, Pahlaviani FG, Firouzeh MM, Shahbazi M, et al. Prevalence of Tuberculosis in a Prison in Tehran by Active Case Finding. Infect Disord Drug Targets. 2019;19(2):167-170. doi: 10.2174/1871526518666180507122425.
Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. Geneva: World Health Organization 1998. Accessed on August 13, 2020. http://whqlibdoc.who.int/hq/1998/WHO_TB_98.250.pdf.
Ali S, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, et al. Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study. PLoS One. 2015;10(12):e0144040. Published 2015 Dec 7. doi:10.1371/journal.pone.0144040.
Treatment of tuberculosis: guidelines for national programs, 3rd ed. Geneva, World Health Organization, 2003. http://www.who.int/tb/ publications/cds_tb_2003_313/en/index.html (accessed August 13, 2020).
Navarro PD, Almeida IN, Kritski AL, Ceccato MD, Maciel MM, Carvalho WD, Miranda SS. Prevalence of latent Mycobacterium tuberculosis infection in prisoners. J Bras Pneumol. 2016;42(5):348-355. doi: 10.1590/S1806-37562016000000001.
Reis AJ, David SM, Nunes LS, Valim AR, Possuelo LG. Recent transmission of drug-resistant Mycobacterium tuberculosis in a prison population in southern Brazil. J Bras Pneumol. 2016;42(4):286-289. doi: 10.1590/S1806-37562016000000023.
Carbonara S, Babudieri S, Longo B, Starnini G, Monarca R, Brunetti B, et al. Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J. 2005;25(6):1070-6. doi: 10.1183/09031936.05.00098104.
Ruvinsky S, Fiorilli G, Pérez MG, Motto E, Cambaceres C, Mannino L, et al. Microbiological features and risk factors for acquiring multidrug-resistant Acinetobacter baumannii bacteremia in pediatric patients. Case-control study. [in Spanish]. Rev Chilena Infectol. 2015 Feb;32(1):19-24. doi: 10.4067/S0716-10182015000200005.
Hsien-Ho Lin, Majid Ezzati, and Megan Murray. Tobacco Smoke, Indoor Air Pollution and Tuberculosis: A Systematic Review and Meta-Analysis. PLoS Med. 2007 Jan; 4(1): e20. doi: 10.1371/journal.pmed.0040020.
Weant TE, Turner AN, Murphy-Weiss M, Murray DM, Wang SH. Can social history variables predict prison prisoners' risk for latent tuberculosis infection? Tuberc Res Treat. 2012;2012:132406. doi: 10.1155/2012/132406.
Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121(4):550-67.
López de Goicoechea-Saiz ME, Sternberg F, Portilla-Sogorb J. Prevalence and associated risk factors of latent tuberculosis infection in a Spanish prison. Rev Esp Sanid Penit. 2018;20(1):4-10.
Sacchi FP, Praça RM, Tatara MB, Simonsen V, Ferrazoli L, Croda MG, et al. Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg Infect Dis. 2015 Mar;21(3):452-5. doi: 10.3201/eid2103.140896.
- Abstract Viewed: 355 times
- PDF Downloaded: 241 times